S. 3807 · 109th Congress

Enhancing Drug Safety and Innovation Act of 2006

Stage: In committee
Sponsor: Michael Enzi
Introduced: 2006-08-03
Latest action: 2006-11-16 · Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-850.

Subjects

Health

Department of Health and Human Services

Commerce

Food and Drug Administration (FDA)

Science, Technology, Communications

Government Operations and Politics

Research centers

Drug approvals

Drugs

Federal advisory bodies

Pharmaceutical research

Government paperwork

Medical supplies

Medical technology

Technological innovations

Product development

Data banks

Product safety

Financial disclosure

Labeling

Executive reorganization

Drug industry

Drug utilization

Risk

Clinical trials

Drug interactions

Conflict of interests

Biomedical engineering